Delivery Order SPE2DB24D2205-SPE2DB25FEJBN
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Sumatriptan Succinate 25 mg tablets in unit dose packages of nine units, with a ceiling value of $5,458.34 and a firm fixed price structure. The contract, which is not set-aside and competitively awarded, is scheduled for completion by September 12, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $18,476.98 to AmerisourceBergen Drug Corp for the supply of Sumatriptan Succinate 25 mg tablets (9-count packages) on September 10, 2025, with completion targeted for September 11, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under...
- The Defense Logistics Agency awarded a delivery order valued at $5,105.59 to AmerisourceBergen Drug Corp for 9 tablets of Sumatriptan Succinate 25 mg on April 24, 2025, with an ultimate completion date of April 25, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The pharmaceutical supply will be performed at the contractor's...
- The Defense Logistics Agency awarded a delivery order valued at $5,859.73 to AmerisourceBergen Drug Corp for the supply of Sumatriptan Succinate 25 mg tablets (9-count packaging) with a firm fixed price arrangement. The order, issued on July 18, 2025, with an ultimate completion date of July 21, 2025, represents a non-set-aside competitive procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location. This...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp, valued at $4,109.67, for the supply of Sumatriptan Succinate 25 mg tablets in quantities of nine units. This non-set-aside, competitively awarded contract operates under a firm fixed-price delivery order model with an ultimate completion date of June 3, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and will perform the work at its corporate office...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Sumatriptan Succinate 25 mg tablets in a package quantity of 9 units. This is a firm fixed-price delivery order with a ceiling value of $2,493.06 and an ultimate completion date of July 24, 2025. The contract was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Sumatriptan Succinate 25 mg tablets in unit dose packaging (9-count). This contract, valued at approximately $20.5K, represents a competitive, firm fixed-price delivery order with no set-aside designation. The ultimate completion date is scheduled for September 12, 2025, and performance will take place at AmerisourceBergen's corporate headquarters in Conshohocken,...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Sumatriptan 20mg in a six-pack quantity, valued at $12,380.92. This is a firm fixed-price delivery order with no set-aside designation, indicating the award resulted from open competition. The contract is scheduled for completion by October 14, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order valued at $3,164.01 to AmerisourceBergen Drug Corp for the supply of Sumatriptan Succinate 100 mg tablets in unit dose packaging (9-count). This is a firm fixed price, competitively awarded contract with no set-aside designation, with ultimate completion scheduled for July 30, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this delivery order from its corporate...
- The U.S. Defense Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Sumatriptan Succinate 25 mg tablets in a quantity of 9 units, with a ceiling value of $3,947.36. This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of July 25, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB25FEJBNDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $27,757.28 to AmerisourceBergen Drug Corp for the supply of Sumatriptan Succinate 25 mg tablets in unit dose packages of nine tablets. This firm fixed price delivery order, issued on September 25, 2025, with an ultimate completion date of September 26, 2025, will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a non-competitive delivery order under an existing contract vehicle, reflecting the established relationship between DLA and AmerisourceBergen for pharmaceutical procurement. This delivery order is issued under AmerisourceBergen Drug Corp's significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor and critical federal medical supply vendor, AmerisourceBergen serves military and veteran healthcare systems through this comprehensive global pharmaceutical support vehicle. The IDC enables the company to supply a broad range of pharmaceutical products including specialty medications, brand-name and generic drugs, and vaccines across multiple therapeutic domains, with this specific delivery order providing migraine treatment medication to support federal healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $27.8k | 9/25/25 |